You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ETOPOSIDE (VP-16)

Showing 1 - 25 of 7,045
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer Trial (Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab))

Not yet recruiting
  • HER2-positive Breast Cancer
  • Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab)
  • (no location specified)
Jul 20, 2023

Leukemia Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

Not yet recruiting
  • Neuroendocrine Carcinoma of the Bladder
  • Bladder Cancer
  • (no location specified)
Oct 14, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2023

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Duarte, California
  • +3 more
Oct 24, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Unilateral Retinoblastoma Trial (Biospecimen Collection,

Not yet recruiting
  • Bilateral Retinoblastoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • (no location specified)
Aug 17, 2022

ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial

Recruiting
  • ENSAT Stage I Adrenal Cortex Carcinoma
  • +2 more
  • Ann Arbor, Michigan
  • +3 more
Dec 13, 2022

HIV, Lymphoma Trial in Zhanjiang (KL-7SHRNA injection solution)

Recruiting
  • HIV Infections
  • Lymphoma
  • KL-7SHRNA injection solution
  • Zhanjiang, Guangdong, China
    Affiliated hospital of Guangdong medical university
Jun 24, 2023

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Extensive Stage Lung Small Cell Carcinoma Trial in Duarte (Atezolizumab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC

Terminated
Has Results
  • Multiple Myeloma
  • myPRS
  • +6 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
May 28, 2021

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • Induction Chemotherapy
  • +3 more
  • Palo Alto, California
  • +5 more
Nov 29, 2022

Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)

Recruiting
  • Chidamide
  • Hemophagocytic Lymphohistiocytosis
  • Chidamide combines with VP-16 and methylprednisolone
  • Beijing, Beijing, China
    Beijing Friendship Hospital
Nov 29, 2021

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,

Terminated
Has Results
  • Leukemia
  • +2 more
  • Ciprofloxacin 750 MG
  • +3 more
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
Jul 5, 2022

Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jun 5, 2023

Ovarian Cancer Trial in Shanghai (Etoposide, Cyclophosphamide, Carboplatin)

Active, not recruiting
  • Ovarian Cancer
  • Etoposide, Cyclophosphamide, Carboplatin
  • Shanghai, Shanghai, China
    Wu Xiaohua
Jul 25, 2022

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

Withdrawn
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Richter Syndrome, Chronic Lymphocytic Leukemia Trial in New York (Polatuzumab Vedotin, Rituximab, Etoposide)

Recruiting
  • Richter Syndrome
  • Chronic Lymphocytic Leukemia
  • Polatuzumab Vedotin
  • +5 more
  • New York, New York
    Weill Cornell Medicine
Dec 19, 2022